PD-1 inhibition in sarcoma still needs investigation - Authors' reply

Lancet Oncol. 2018 Jan;19(1):e7. doi: 10.1016/S1470-2045(17)30922-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Programmed Cell Death 1 Receptor*
  • Sarcoma*

Substances

  • Programmed Cell Death 1 Receptor